Search Results - "Hope, Russell"

Refine Results
  1. 1

    Incidence and aetiology of infant Gram-negative bacteraemia and meningitis: systematic review and meta-analysis by Hallmaier-Wacker, Luisa K, Andrews, Amelia, Nsonwu, Olisaeloka, Demirjian, Alicia, Hope, Russell J, Lamagni, Theresa, Collin, Simon M

    Published in Archives of disease in childhood (16-06-2022)
    “…BackgroundOne in six infant deaths worldwide are caused by invasive bacterial infections, of which a substantial but unquantified proportion are caused by…”
    Get full text
    Journal Article
  2. 2
  3. 3

    Trends in COVID-19 hospital outcomes in England before and after vaccine introduction, a cohort study by Kirwan, Peter D., Charlett, Andre, Birrell, Paul, Elgohari, Suzanne, Hope, Russell, Mandal, Sema, De Angelis, Daniela, Presanis, Anne M.

    Published in Nature communications (17-08-2022)
    “…Widespread vaccination campaigns have changed the landscape for COVID-19, vastly altering symptoms and reducing morbidity and mortality. We estimate trends in…”
    Get full text
    Journal Article
  4. 4

    The health and cost burden of antibiotic resistant and susceptible Escherichia coli bacteraemia in the English hospital setting: A national retrospective cohort study by Naylor, Nichola R, Pouwels, Koen B, Hope, Russell, Green, Nathan, Henderson, Katherine L, Knight, Gwenan M, Atun, Rifat, Robotham, Julie V, Deeny, Sarah R

    Published in PloS one (10-09-2019)
    “…Antibiotic resistance poses a threat to public health and healthcare systems. Escherichia coli causes more bacteraemia episodes in England than any other…”
    Get full text
    Journal Article
  5. 5

    Clinical and Molecular Epidemiology of Staphylococcal Toxic Shock Syndrome in the United Kingdom by Sharma, Hema, Smith, Debra, Turner, Claire E, Game, Laurence, Pichon, Bruno, Hope, Russell, Hill, Robert, Kearns, Angela, Sriskandan, Shiranee

    Published in Emerging infectious diseases (01-02-2018)
    “…Staphylococcal toxic shock syndrome (TSS) was originally described in menstruating women and linked to TSS toxin 1 (TSST-1)-producing Staphylococcus aureus…”
    Get full text
    Journal Article
  6. 6
  7. 7

    Estimation of the impact of hospital-onset SARS-CoV-2 infections on length of stay in English hospitals using causal inference by Stimson, James, Pouwels, Koen B, Hope, Russell, Cooper, Ben S, Presanis, Anne M, Robotham, Julie V

    Published in BMC infectious diseases (09-12-2022)
    “…From March 2020 through August 2021, 97,762 hospital-onset SARS-CoV-2 infections were detected in English hospitals. Resulting excess length of stay (LoS)…”
    Get full text
    Journal Article
  8. 8

    Evaluating the impact of testing strategies for the detection of nosocomial COVID-19 in English hospitals through data-driven modeling by Evans, Stephanie, Stimson, James, Pople, Diane, Wilcox, Mark H., Hope, Russell, Robotham, Julie V.

    Published in Frontiers in medicine (11-10-2023)
    “…Introduction During the first wave of the COVID-19 pandemic 293,204 inpatients in England tested positive for SARS-CoV-2. It is estimated that 1% of these…”
    Get full text
    Journal Article
  9. 9
  10. 10

    Using hospital network-based surveillance for antimicrobial resistance as a more robust alternative to self-reporting by Donker, Tjibbe, Smieszek, Timo, Henderson, Katherine L, Walker, Timothy M, Hope, Russell, Johnson, Alan P, Woodford, Neil, Crook, Derrick W, Peto, Tim E A, Walker, A Sarah, Robotham, Julie V

    Published in PloS one (25-07-2019)
    “…Hospital performance is often measured using self-reported statistics, such as the incidence of hospital-transmitted micro-organisms or those exhibiting…”
    Get full text
    Journal Article
  11. 11

    Using linked electronic health records to report healthcare-associated infections by Quan, T Phuong, Hope, Russell, Clarke, Tiphanie, Moroney, Ruth, Butcher, Lisa, Knight, Peter, Crook, Derrick, Hopkins, Susan, Peto, Timothy E A, Johnson, Alan P, Walker, A Sarah

    Published in PloS one (07-11-2018)
    “…Reporting of strategic healthcare-associated infections (HCAIs) to Public Health England is mandatory for all acute hospital trusts in England, via a web-based…”
    Get full text
    Journal Article
  12. 12

    Predicting future hospital antimicrobial resistance prevalence using machine learning by Vihta, Karina-Doris, Pritchard, Emma, Pouwels, Koen B., Hopkins, Susan, Guy, Rebecca L., Henderson, Katherine, Chudasama, Dimple, Hope, Russell, Muller-Pebody, Berit, Walker, Ann Sarah, Clifton, David, Eyre, David W.

    Published in Communications medicine (10-10-2024)
    “…Background Predicting antimicrobial resistance (AMR), a top global health threat, nationwide at an aggregate hospital level could help target interventions…”
    Get full text
    Journal Article
  13. 13

    Descriptive epidemiology of Escherichia coli bacteraemia in England, April 2012 to March 2014 by Bou-Antoun, Sabine, Davies, John, Guy, Rebecca, Johnson, Alan P, Sheridan, Elizabeth A, Hope, Russell J

    “…We determined the incidence, risk factors and antimicrobial susceptibility associated with Escherichia coli bacteraemia in England over a 24 month period. Case…”
    Get full text
    Journal Article
  14. 14

    Nosocomial transmission of C. difficile in English hospitals from patients with symptomatic infection by van Kleef, Esther, Gasparrini, Antonio, Guy, Rebecca, Cookson, Barry, Hope, Russell, Jit, Mark, Robotham, Julie V, Deeny, Sarah R, Edmunds, W John

    Published in PloS one (16-06-2014)
    “…Recent evidence suggests that less than one-quarter of patients with symptomatic nosocomial Clostridium difficile infections (CDI) are linked to other…”
    Get full text
    Journal Article
  15. 15

    Activity of faropenem against cephalosporin-resistant Enterobacteriaceae by Mushtaq, Shazad, Hope, Russell, Warner, Marina, Livermore, David M.

    Published in Journal of antimicrobial chemotherapy (01-05-2007)
    “…Background There is a need for new oral agents active against extended-spectrum β-lactamase (ESBL) producers, as these increasingly cause community-onset…”
    Get full text
    Journal Article
  16. 16
  17. 17
  18. 18
  19. 19

    Hospital admission and emergency care attendance risk for SARS-CoV-2 delta (B.1.617.2) compared with alpha (B.1.1.7) variants of concern: a cohort study by Aliabadi, Shirin, Lopez-Bernal, Jamie, Moore, Nathan, Golubchik, Tanya, Cogger, Benjamin, Wantoch, Michelle, Spellman, Karla, McCluggage, Kathryn, Munn, Robert, Fuller, William, Charalampous, Themoula, Robson, Samuel, Abudahab, Khalil, Willingham, Iona, Raviprakash, Veena, Loose, Matthew, Coll, Francesc, Wilson, Harry, Pybus, Oliver, Zarebski, Alex, Jahun, Aminu, Fisher, Chloe, Siveroni, Igor, Boyd, Olivia, Smollett, Katherine, Poplawski, Radoslaw, Sluga, Graciela, Nichols, Jenna, Johnson, Natasha, Singer, Joshua, Nickbakhsh, Seema, Carden, Holli, Taha, Yusri, Blacow, Rachel, McHugh, Martin, Stanley, Rachael, Meader, Emma, Coupland, Lindsay, Peto, Timothy, Sloan, Tim, Chauhan, Anoop, Pearson, Clare, Robinson, Esther, Muir, Peter, Pymont, Hannah, Hutchings, Stephanie, Bibby, David, Lee, David, Ellaby, Nicholas, Manesis, Nikos, Bishop, Chloe, Gaskin, Amy, Gatica-Wilcox, Bree, Cronin, Michelle, Cottrell, Simon, Edwards, Sue, Aydin, Alp, Ratcliffe, Liz, Acheson, Erwan, Ellard, Sian, Irish-Tavares, Dianne, Hart, Jennifer, Symmonds, Amanda, Bourgeois, Yann, Dent, Hannah, Paul, Hannah, Partridge, David, Bonner, Stephen, Silveira, Siona, Williams, Charlotte, Jeremiah, Sarah, Berry, Lisa, Jones, Katie, Percival, Benita, Hesketh, Andrew, Girgis, Sophia, Forrest, Sally, Gupta, Ravi, Ludden, Catherine, Bewshea, Claire, Temperton, Ben, Warwick-Dugdale, Joanna, Studholme, David, Jeffries, Aaron, Jackson, Kathryn, Gregory, Richard, Wierzbicki, Claudia, Green, Luke, Freeman, Timothy, Cerda, Alberto, Alderton, Alex, Amato, Roberto, Ariani, Cristina, Beale, Mathew, Bellis, Katherine, Kwiatkowski, Dominic, McGuigan, Samantha, Prestwood, Liam, Spencer Chapman, Michael, Tonkin-Hill, Gerry

    Published in The Lancet infectious diseases (01-01-2022)
    “…The SARS-CoV-2 delta (B.1.617.2) variant was first detected in England in March, 2021. It has since rapidly become the predominant lineage, owing to high…”
    Get full text
    Journal Article
  20. 20